OS THERAPIES

Lobbying client · New York · filed 2025 to 2026

biotechnology company

$0 Reported spend

6 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page comes from one LDA client record (69263), filed by the registrant listed below.

Who filed for this client 1

CHAMBER HILL STRATEGIES $0 Outside firm · 6 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $0 3 filings
2025 $0 3 filings

Issues lobbied 2

Health Issues 6
Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

Food & Drug Administration (FDA) 5
Health & Human Services, Dept of (HHS) 5
HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 6 total

Q3 report

CHAMBER HILL STRATEGIES

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · posted Oct 19, 2026

View → Q2 report

CHAMBER HILL STRATEGIES

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · posted Jul 19, 2026

View → Q1 report

CHAMBER HILL STRATEGIES

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted Apr 6, 2026

View → Q4 report

CHAMBER HILL STRATEGIES

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · posted Jan 20, 2026

View → Q3 report

CHAMBER HILL STRATEGIES

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · posted Oct 17, 2025

View → Registration

CHAMBER HILL STRATEGIES

3rd Quarter 2025 (July 1 - Sep 30) · posted Oct 16, 2025

View →

Keep going

Filings through October 19, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.